Exagen [XGN] vs Thermo Fisher [TMO] Detailed Stock Comparison

Exagen Inc.

NASDAQ
Loading...

Thermo Fisher Scientific Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Exagen Inc. wins in 2 metrics, Thermo Fisher Scientific Inc. wins in 15 metrics, with 0 ties. Thermo Fisher Scientific Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Exagen Inc. Thermo Fisher Scientific Inc. Better
P/E Ratio (TTM) N/A 25.84 N/A
Price-to-Book Ratio 3.52 3.31 Thermo Fisher Scientific Inc.
Debt-to-Equity Ratio 158.55 82.91 Thermo Fisher Scientific Inc.
PEG Ratio -5.96 2.29 Thermo Fisher Scientific Inc.
EV/EBITDA -5.01 19.02 Thermo Fisher Scientific Inc.
Profit Margin (TTM) -29.97% 15.15% Thermo Fisher Scientific Inc.
Operating Margin (TTM) -29.91% 17.89% Thermo Fisher Scientific Inc.
EBITDA Margin (TTM) N/A 17.89% N/A
Return on Equity -147.85% 13.52% Thermo Fisher Scientific Inc.
Return on Assets (TTM) -17.12% 5.00% Thermo Fisher Scientific Inc.
Free Cash Flow (TTM) $-14.27M $6.29B Thermo Fisher Scientific Inc.
Dividend Yield N/A 0.38% N/A
1-Year Return -28.35% 22.27% Thermo Fisher Scientific Inc.
Price-to-Sales Ratio (TTM) 0.97 3.86 Exagen Inc.
Enterprise Value $59.91M $214.76B Thermo Fisher Scientific Inc.
EV/Revenue Ratio 0.90 4.75 Exagen Inc.
Gross Profit Margin (TTM) 55.35% N/A N/A
Revenue per Share (TTM) $3 $120 Thermo Fisher Scientific Inc.
Earnings per Share (Diluted) $-0.93 $18.18 Thermo Fisher Scientific Inc.
Beta (Stock Volatility) 1.94 0.97 Thermo Fisher Scientific Inc.
Short % of Float 7.67% 1.22% Thermo Fisher Scientific Inc.

Exagen Inc. vs Thermo Fisher Scientific Inc. Stock Performance Analysis

Loading Price Chart...

XGN
TMO

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Exagen Inc.-6.02%4.33%55.48%35.77%-32.11%-20.20%
Thermo Fisher Scientific Inc.-1.69%7.56%4.21%-5.21%-16.94%-18.64%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Exagen Inc.-28.35%61.17%-62.64%-70.71%-70.71%-70.71%
Thermo Fisher Scientific Inc.22.27%-5.31%9.75%222.18%684.25%1,233.99%

Performance & Financial Health Analysis: Exagen Inc. vs Thermo Fisher Scientific Inc.

MetricXGNTMO
Market Information
Market Cap i$64.46M$174.55B
Market Cap CategoryMicro capLarge cap
10 Day Avg. Volume i206,1382,356,220
90 Day Avg. Volume i219,9292,071,517
Last Close$4.53$473.95
52 Week Range$2.59 - $12.23$385.46 - $643.99
% from 52W High-62.96%-26.40%
All-Time High$29.86 (Dec 23, 2019)$672.34 (Dec 27, 2021)
% from All-Time High-84.83%-29.51%
Growth Metrics
Quarterly Revenue Growth0.22%0.06%
Quarterly Earnings Growth0.22%0.10%
Financial Health
Profit Margin (TTM) i-0.30%0.15%
Operating Margin (TTM) i-0.30%0.18%
Return on Equity (TTM) i-1.48%0.14%
Debt to Equity (MRQ) i158.5582.91
Cash & Liquidity
Book Value per Share (MRQ)$0.76$141.96
Cash per Share (MRQ)$1.34$8.75
Operating Cash Flow (TTM) i$-13,625,000$8.29B
Levered Free Cash Flow (TTM) i$-10,364,500$5.51B
Dividends
Last 12-Month Dividend Yield iN/A0.38%
Last 12-Month Dividend iN/A$1.76

Valuation & Enterprise Metrics Analysis: Exagen Inc. vs Thermo Fisher Scientific Inc.

MetricXGN (Apr 24, 2026)TMO (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) iN/A25.84
Forward P/E i-5.9617.16
PEG Ratio i-5.962.29
Price to Sales (TTM) i0.973.86
Price to Book (MRQ) i3.523.31
Market Capitalization
Market Capitalization i$64.46M$174.55B
Enterprise Value i$59.91M$214.76B
Enterprise Value Metrics
Enterprise to Revenue i0.904.75
Enterprise to EBITDA i-5.0119.02
Risk & Other Metrics
Beta i1.940.97
Book Value per Share (MRQ) i$0.76$141.96

Financial Statements Comparison: Exagen Inc. vs Thermo Fisher Scientific Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricXGN (2025)TMO (2025)
Revenue/Sales i66.58M44.56B
Cost of Goods Sold i27.78M26.32B
COGS % of Revenue i41.7%59.1%
Gross Profit i38.80M18.24B
Gross Margin i58.3%40.9%
Research & Development i6.25M1.40B
Operating Income (EBIT) i-14.07M8.11B
Operating Margin i-21.1%18.2%
EBITDA i-11.66M11.86B
EBITDA Margin i-17.5%26.6%
Pre-Tax Income i-19.90M7.31B
Pre-Tax Income % of Revenue i-29.9%16.4%
Income Tax i51,000547.00M
Income Tax % of Revenue i0.1%1.2%
Net Income (Profit) i-19.95M6.72B
Profit Margin i-30.0%15.1%

Balance Sheet & Liquidity Metrics

MetricXGN (2025)TMO (2025)
Cash & Equivalents i32.22M9.85B
Total Current Assets i48.89M28.71B
Total Current Assets % of Revenue i73.4%64.4%
Total Current Liabilities i14.16M15.19B
Total Current Liabilities % of Revenue i21.3%34.1%
Long-Term Debt i22.70M35.85B
Long-Term Debt % of Revenue i34.1%80.5%
Total Shareholders Equity i17.45M53.54B
Retained Earnings i-314.28M59.16B
Retained Earnings % of Revenue i-472.1%132.8%
Property, Plant & Equipment i9.67M0

Cash Flow Statement Comparison

MetricXGN (2025)TMO (2025)
Operating Cash Flow i-16.79M7.82B
Operating Cash Flow % of Revenue i-25.2%17.5%
Capital Expenditures i-626,000-1.48B
Free Cash Flow i-14.27M6.29B
FCF Margin i-21.4%14.1%
Debt Repayment i-20.79M-3.51B
Common Stock Repurchase iN/A-3.00B

Short Interest & Institutional Ownership Analysis

MetricXGNTMO
Shares Short i1.53M4.54M
Short Ratio i4.902.38
Short % of Float i7.67%1.22%
Shares Outstanding i22.91M371.62M
Float Shares i16.17M371.07M
% Held by Insiders i18.09%0.17%
% Held by Institutions i59.71%95.23%
% Held by Public i22.20%4.60%

Dividend Analysis & Yield Comparison: Exagen Inc. vs Thermo Fisher Scientific Inc.

MetricXGNTMO
Last 12-Month Dividend iN/A$1.76
Last 12-Month Dividend Yield iN/A0.38%
3-Year Avg Annual Dividend iN/A$1.60
3-Year Avg Dividend Yield iN/A0.08%
3-Year Total Dividends iN/A$4.80
Ex-Dividend DateN/AMar 13, 2026